The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels
Abstract
IMPORTANCE: Rates of testosterone therapy are increasing and the effects of testosterone therapy on cardiovascular outcomes and mortality are unknown. A recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiovascular diseases was stopped prematurely due to adverse cardiovascular events raising concerns about testosterone therapy safety. OBJECTIVES: To assess the association between testosterone therapy and all-cause mortality, myocardial infarction (MI), or stroke among male veterans and to determine whether this association is modified by underlying coronary artery disease. DESIGN, SETTING, AND PATIENTS: A retrospective national cohort study of men with low testosterone levels (<300 ng/dL) who underwent coronary angiography in the Veterans Affairs (VA) system between 2005 and 2011. MAIN OUTCOMES AND MEASURES: Primary outcome was a composite of all-cause mortality, MI, and ischemic stroke. RESULTS: Of the 8709 men with a total testosterone level lower than 300 ng/dL, 1223 patients started testosterone therapy after a median of 531 days following coronary angiography. Of the 1710 outcome events, 748 men died, 443 had MIs, and 519 had strokes. Of 7486 patients not receiving testosterone therapy, 681 died, 420 had MIs, and 486 had strokes. Among 1223 patients receiving testosterone therapy, 67 died, 23 had MIs, and 33 had strokes. At 3 years after coronary angiography, the Kaplan-Meier estimated cumulative percentages with events were 19.9%in the no testosterone therapy group vs 25.7%in the testosterone therapy group,with an absolute risk difference of 5.8%(95%CI, -1.4%to 13.1%) [corrected].The Kaplan-Meier estimated cumulative percentages with events among the no testosterone therapy group vs testosterone therapy group at 1 year after coronary angiography were 10.1% vs 11.3%; at 2 years, 15.4% vs 18.5%; and at 3 years, 19.9% vs 25.7 [corrected].There was no significant difference in the effect size of testosterone therapy among those with and without coronary artery disease (test for interaction, P = .41). CONCLUSIONS AND RELEVANCE: Among a cohort of men in the VA health care system who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of adverse outcomes. These findings may inform the discussion about the potential risks of testosterone therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the authors identified a higher rate of AEs in the T supplementation group (after statistical manipulation of the raw data), given the wide discrepancy in groupings, it is unclear if this group represented men with a higher baseline risk for subsequent events and that a lower T in this group was an indirect indicator of their overall comorbid burdens (despite lower ages).”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [129]
In the citing paper
“Additionally, groupings were not matched for age or T levels.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [129]
In the citing paper
“One recent example of poorly matched groupings was the Vigen et al’s retrospective analysis of a VA population, which compared hypogonadal men receiving or not receiving T supplementation.129 Baseline comorbid states were significantly different between groupings, including obesity, obstructed coronary artery status, hypertension, hyperlipidemia, myocardial infarction, and cerebrovascular disease,”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [129]
In the citing paper
“Some epidemiological studies have reported an increase in cardiovascular mortality related to TRT while others have not been able to establish a correlation between the two [19,20].”
Citations
Cites
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,213
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,837
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Isidori, A. M., Giannetta, E., Greco, E. A., Gianfrilli, D., Bonifacio, V., Isidori, A., Lenzi, A., & Fabbri, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02339.x · Cited by 695
Effects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 610
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1233 · Cited by 548
Cited by
Sorted by citations
Items 101–200 of 999
Sharma, R., Oni, O. A., Gupta, K., Sharma, M., Sharma, R., Singh, V., Parashara, D., Surineni, K., Dawn, B., Chen, G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004880 · Cited by 86
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170009 · Cited by 113
Bhasin, S., Lincoff, A. M., Basaria, S. S., Bauer, D. C., Boden, W. E., Cunningham, G. R., Davey, D. A., Dubcenco, E., Fukumoto, S., Garcia, M., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.11.016 · Cited by 88
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
Loeb, S., Folkvaljon, Y., Damber, J., Alukal, J. P., Lambe, M. P., & Stattin, P. E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.5304 · Cited by 84
Importance of sex and gender in atherosclerosis and cardiovascular disease
Spence, J. D., & Pilote, L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.806 · Cited by 83
Kohn, T. P., Mata, D. A., Ramasamy, R., & Lipshultz, L. I. (2016) · European Urology · doi:10.1016/j.eururo.2016.01.043 · Cited by 88
Testosterone deficiency: A determinant of aortic stiffness in men
Vlachopoulos, C. V., Ioakeimidis, N., Miner, M. M., Aggelis, A., Pietri, P. G., Terentes-Printzios, D. G., Tsekoura, D., & Stefanadis, C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.010 · Cited by 82
Gharahdaghi, N., Rudrappa, S. S., Brook, M. S., IDRIS, I. R., Crossland, H., Hamrock, C., Aziz, M. H. A., Kadi, F., Tarum, J., Greenhaff, P. L., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12472 · Cited by 88
Haematological manifestations of human immune deficiency virus infection
Vishnu, P., & Aboulafia, D. M. (2015) · British Journal of Haematology · doi:10.1111/bjh.13783 · Cited by 80
Off-label use of hormones as an antiaging strategy: a review
Samaras, N., Papadopoulou, M.-A., Samaras, D., & Ongaro, F. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48918 · Cited by 83
The Endocrinology of Ageing: A Mini-Review
Jones, C. M., & Boelaert, K. (2014) · Gerontology · doi:10.1159/000367692 · Cited by 83
Sex‐specific and hormone‐related differences in vascular remodelling in atherosclerosis
Yerly, A., van der Vorst, E. P. C., Baumgärtner, I., Bernhard, S., Schindewolf, M., & Döring, Y. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13885 · Cited by 86
Morgan, D. J., Wright, S. M., & Dhruva, S. S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5444 · Cited by 78
Testosterone therapy, thrombosis, thrombophilia, cardiovascular events
Glueck, C. J., & Wang, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.005 · Cited by 79
Francomano, D., Bruzziches, R., Bárbaro, G., Lenzi, A., & Aversa, A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0066-9 · Cited by 76
Muraleedharan, V., & Jones, T. H. (2014) · Clinical Endocrinology · doi:10.1111/cen.12503 · Cited by 78
Injectable testosterone undecanoate for the treatment of hypogonadism
Corona, G., Maseroli, E., & Maggi, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944896 · Cited by 79
Rao, P., Boulet, S. L., Mehta, A., Hotaling, J. M., Eisenberg, M. L., Honig, S. C., Warner, L., Kissin, D. M., Nangia, A. K., & Ross, L. S. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.10.063 · Cited by 77
Testosterone Therapy: What We Have Learned From Trials
Corona, G., Torres, L. O., & Maggi, M. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.11.270 · Cited by 78
Srinath, R., Golden, S. H., Carson, K. A., & Dobs, A. S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3934 · Cited by 74
The practical management of testosterone deficiency in men
Aversa, A., & Morgentaler, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.238 · Cited by 75
Uncovering sex-specific mechanisms of action of testosterone and redox balance
Cruz‐Topete, D., Dominic, P. S., & Stokes, K. Y. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101490 · Cited by 77
Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction
Podlasek, C. A., Mulhall, J. P., Davies, K. P., Wingard, C. J., Hannan, J. L., Bivalacqua, T. J., Musicki, B., Khera, M., González-Cadavid, N. F., & Burnett, A. L. “. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.06.004 · Cited by 74
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 75
Goodman, N. F., Guay, A. T., Dandona, P., Dhindsa, S., Faiman, C., & Cunningham, G. R. (2015) · Endocrine Practice · doi:10.4158/ep14434.ps · Cited by 72
Steroid secretion in healthy aging
Fiacco, S., Walther, A., & Ehlert, U. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.035 · Cited by 71
Diem, S. J., Greer, N. L., MacDonald, R. H., McKenzie, L. G., Dahm, P., Ercan-Fang, N. G., Estrada, A., Hemmy, L. S., Rosebush, C. E., Fink, H. A., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-0830 · Cited by 72
Effect of lifestyle intervention on the hormonal profile of frail, obese older men
Armamento-Villareal, R., Aguirre, L. E., Qualls, C., & Villareal, D. T. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0698-x · Cited by 67
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone
dos Santos, M. R., & Bhasin, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-050219-034711 · Cited by 71
Update of the position paper on arterial hypertension and erectile dysfunction
Viigimaa, M., Vlachopoulos, C. V., Doumas, M. N., Wolf, J., Imprialos, K. P., Terentes-Printzios, D. G., Ioakeimidis, N., Kotsar, A., Kiitam, U., Stavropoulos, K., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002382 · Cited by 69
Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism
Sharma, R., Oni, O. A., Chen, G., Sharma, M., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Barua, R. S., & Gupta, K. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.007 · Cited by 68
Serum testosterone levels in male hypogonadism: Why and when to check-A review
Livingston, M. A., Kalansooriya, A., Hartland, A. J., Ramachandran, S., & Heald, A. H. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12995 · Cited by 66
Morgentaler, A., Traish, A. M., Hackett, G. I., Jones, T. H., & Ramasamy, R. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.06.003 · Cited by 67
Critical evaluation of different available guidelines for late‐onset hypogonadism
Giagulli, V., Castellana, M., Lisco, G., & Triggiani, V. (2020) · Andrology · doi:10.1111/andr.12850 · Cited by 54
The Endocrine Role of Estrogens on Human Male Skeleton
Rochira, V., Kara, E., & Carani, C. (2015) · International Journal of Endocrinology · doi:10.1155/2015/165215 · Cited by 69
Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism
Seftel, A. D., Kathrins, M. N., & Niederberger, C. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.06.002 · Cited by 63
Male Hormonal Contraception: Where Are We Now?
Wang, C., Festin, M., & Swerdloff, R. S. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0140-8 · Cited by 63
Borst, S. E., & Yarrow, J. F. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2015 · Cited by 63
Role of androgens in cardiovascular pathology
Chistiakov, D. A., Myasoedova, V. A., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2018) · Vascular Health and Risk Management · doi:10.2147/vhrm.s173259 · Cited by 65
Screening and Monitoring in Men Prescribed Testosterone Therapy in the U.S., 2001–2010
Baillargeon, J., Urban, R. J., Kuo, Y.-F., Holmes, H. M., Raji, M. A., Morgentaler, A., Howrey, B. T., Lin, Y.-L., & Ottenbacher, K. J. (2015) · Public Health Reports® · doi:10.1177/003335491513000207 · Cited by 61
Death by Testosterone? We Think Not!
Traish, A. M., Guay, A. T., & Morgentaler, A. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12464 · Cited by 61
Testosterone Treatment and Cardiovascular and Venous Thromboembolism Risk: What is ‘New’?
Corona, G., Dicuio, M., Rastrelli, G., Maseroli, E., Lotti, F., Sforza, A., & Maggi, M. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000411 · Cited by 61
Babcock, M. C., DuBose, L. E., Witten, T. L., Stauffer, B. L., Hildreth, K. L., Schwartz, R. S., Kohrt, W. M., & Moreau, K. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab715 · Cited by 64
Bendayan, M., Bibas, L., Levi, M., Mullie, L., Forman, D. E., & Afilalo, J. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.07.005 · Cited by 63
Meriggiola, M. C., & Gava, G. (2015) · Clinical Endocrinology · doi:10.1111/cen.12753 · Cited by 61
Testosterone Replacement Therapy: Long-Term Safety and Efficacy
Corona, G., Sforza, A., & Maggi, M. (2017) · The World Journal of Men s Health · doi:10.5534/wjmh.2017.35.2.65 · Cited by 60
Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study
Etminan, M., Skeldon, S., Goldenberg, S. L., Carleton, B., & Brophy, J. M. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1534 · Cited by 59
Practical Use of Pharmacotherapy for Obesity
Igel, L. I., Kumar, R. B., Saunders, K. H., & Aronne, L. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.049 · Cited by 59
Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and Health
Willemars, M. M. A., Nabben, M., Verdonschot, J. A. J., & Hoes, M. F. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00555-0 · Cited by 63
Male hypogonadism: pathogenesis, diagnosis, and management
de Silva, N. L., Papanikolaou, N., Grossmann, M., Antonio, L., Quinton, R., Anawalt, B. D., & Jayasena, C. N. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00199-2 · Cited by 68
Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study
Pickering, A. N., Hamm, M., Dawdani, A., Hanlon, J. T., Thorpe, C. T., Gellad, W. F., & Radomski, T. R. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16370 · Cited by 61
Glišić, M., Mujaj, B., Rueda-Ochoa, O. L., Asllanaj, E., Laven, J. S. E., Kavousi, M., Ikram, M. K., Vernooij, M. W., Ikram, M. A., Franco, O. H., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311681 · Cited by 62
Traish, A. M., & Zitzmann, M. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9323-2 · Cited by 57
Anabolic androgenic steroids and cardiomyopathy: an update
Fadah, K., Gopi, G., Lingireddy, A., Blumer, V. L., DeWald, T. A., & Mentz, R. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1214374 · Cited by 57
Beggs, L. A., Yarrow, J. F., Conover, C. F., Meuleman, J. R., Beck, D. T., Morrow, M., Zou, B., Shuster, J. J., & Borst, S. E. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2014 · Cited by 59
Compromised endothelial function in transgender men taking testosterone
Gulanski, B., Flannery, C. A., Peter, P. R., Leone, C. A., & Stachenfeld, N. S. (2019) · Clinical Endocrinology · doi:10.1111/cen.14132 · Cited by 60
Cardiovascular implications of gender-affirming hormone treatment in the transgender population
Dutra, E., Lee, J., Torbati, T., Garcia, M. M., Merz, C. N. B., & SHUFELT, C. L. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.08.010 · Cited by 59
EMAS position statement: Testosterone replacement therapy in the aging male
Dimopoulou, C., Ceauşu, I., Depypere, H. T., Lambrinoudaki, I. V., Mueck, A. O., Pérez-López, F. R., Rees, M., van der Schouw, Y. T., Senturk, L. M., Simonsini, T., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.11.003 · Cited by 55
Testosterone Deficiency: A Review and Comparison of Current Guidelines
Kwong, J. C. C., Krakowsky, Y., & Grober, E. D. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.03.262 · Cited by 58
Gencer, B., Bonomi, M., Adorni, M. P., Sirtori, C. R., Mach, F., & Ruscica, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09628-2 · Cited by 58
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Bhasin, S., Hatfield, D. L., Hoffman, J. R., Kraemer, W. J., LaBotz, M., Phillips, S. M., & Ratamess, N. A. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002670 · Cited by 63
Saad, F., Haider, K. S., Yassin, A. A., Doros, G. D., Rosano, G. M. C., & Haider, A. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s108947 · Cited by 58
Effect of biological sex on human circulating lipidome: An overview of the literature
Tabassum, R., Widén, E., & Ripatti, S. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117274 · Cited by 57
Current topics in testosterone replacement of hypogonadal men
Nieschlag, E. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.008 · Cited by 55
Rochira, V., Diazzi, C., Santi, D., Brigante, G., Ansaloni, A., Decaroli, M. C., Vincentis, S. D., Stentarelli, C., Zona, S., & Guaraldi, G. (2015) · Andrology · doi:10.1111/andr.310 · Cited by 54
Sex Differences and Regulatory Actions of Estrogen in Cardiovascular System
Ueda, K., Fukuma, N., Adachi, Y., Numata, G., Tokiwa, H., Toyoda, M., Otani, A., Hashimoto, M., Liu, P., & Takimoto, E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.738218 · Cited by 57
Adverse health effects of testosterone deficiency (TD) in men
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.010 · Cited by 51
Testosterone, aging and survival
Shores, M. M., & Matsumoto, A. M. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000057 · Cited by 52
Boden, W. E., Miller, M. G., McBride, R., Harvey, C., Snabes, M. C., Schmidt, J. M., McGovern, M. E., Fleg, J. L., Desvigne-Nickens, P. M., Anderson, T. J., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.03.016 · Cited by 52
Tritos, N. A., Yuen, K. C. J., & Kelly, D. F. (2015) · Endocrine Practice · doi:10.4158/ep14567.dscr · Cited by 51
Ascertainment of Testosterone Prescribing Practices in the VA
Jasuja, G. K., Bhasin, S., Reisman, J. I., Berlowitz, D. R., & Rose, A. J. (2015) · Medical Care · doi:10.1097/mlr.0000000000000398 · Cited by 51
Daka, B., Langer, R. D., Larsson, C., Rosén, T., Jansson, P. A., Råstam, L., & Lindblad, U. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0034-1 · Cited by 48
Characteristics of Compensated Hypogonadism in Patients with Sexual Dysfunction
Corona, G., Maseroli, E., Rastrelli, G., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12549 · Cited by 51
Testosterone Replacement Therapy and Cardiovascular Risk: A Review
Giovanni Corona, G., Rastrelli, G., Maseroli, E., Sforza, A., & Maggi, M. (2015) · The World Journal of Men s Health · doi:10.5534/wjmh.2015.33.3.130 · Cited by 51
Kirby, M., Hackett, G. I., & Ramachandran, S. (2019) · European Cardiology Review · doi:10.15420/ecr.2019.13.1 · Cited by 53
Klinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk
Chang, S., Christiansen, C. F., Bojesen, A., Juul, S., Münster, A. B., & Gravholt, C. H. (2020) · Endocrine Connections · doi:10.1530/ec-19-0433 · Cited by 50
Maggi, M., Wu, F. C. W., Jones, T. H., Jackson, G., Behre, H. M., Hackett, G. I., Martín‐Morales, A., Balercia, G., Dobs, A. S., Arver, S., et al. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12876 · Cited by 52
Androgen actions on endothelium functions and cardiovascular diseases.
Cai, J., Wen, J., Jiang, W., Lin, J., Yuan, H., & Zhu, Y. (2016) · PubMed · doi:10.11909/j.issn.1671-5411.2016.02.003 · Cited by 54
Marketing and Testosterone Treatment in the USA: A Systematic Review
Bandari, J., Ayyash, O. M., Emery, S., Wessel, C. B., & Davies, B. J. (2017) · European Urology Focus · doi:10.1016/j.euf.2017.10.016 · Cited by 51
Yao, S., Wei, X., Deng, W., Wang, B., Cai, J., Huang, Y., Lai, X., Qiu, Y., Wang, Y., Guan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31755-w · Cited by 54
Allam, S., Elsakka, E. G. E., Ismail, A., Doghish, A. S., Yehia, A. M., Elkady, M. A., Mokhlis, H. A., Sayed, S. M., Elaziz, A. I. A., Hashish, A. A., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121697 · Cited by 49
Testosterone and Cardiovascular Risk in Men
Kelly, D. M., & Jones, T. H. (2014) · Frontiers of hormone research · doi:10.1159/000360553 · Cited by 52
Transdermal delivery of testosterone
Hadgraft, J., & Lane, M. E. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.015 · Cited by 49
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 50
Chung, J., Brown, S., Chen, H., Liu, J., Papadopoulos, V., & Zirkin, B. R. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz174 · Cited by 51
Zhang, H., Basit, A., Busch, D., Yabut, K. C. B., Bhatt, D. K., Droździk, M., Ostrowski, M., Li, A. P., Collins, C. J., Oswald, S., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.003 · Cited by 48
Jayasena, C. N., Alkaabi, F., Liebers, C. S., Handley, T. J., Franks, S., & Dhillo, W. S. (2018) · Clinical Endocrinology · doi:10.1111/cen.13906 · Cited by 51
Safi, R., Wardell, S. E., Watkinson, P., Qin, X., Lee, M., Park, S., Krebs, T., Dolan, E. L., Blattler, A., Tsuji, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52032-y · Cited by 47
Testosterone Treatment Is a Potent Tumor Promoter for the Rat Prostate
Bosland, M. C. (2014) · Endocrinology · doi:10.1210/en.2014-1688 · Cited by 47
Cappuzzo, F., Moro‐Sibilot, D., Gautschi, O. P., Boleti, E., Felip, E., Groen, H. J. M., Germonpré, P. R., Meldgaard, P., Arriola, E., Steele, N. L., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.12.010 · Cited by 47
Klinefelter syndrome and medical treatment: hypogonadism and beyond
Chang, S., Skakkebaek, A. H., & Gravholt, C. H. (2015) · HORMONES · doi:10.14310/horm.2002.1622 · Cited by 50
Loo, S. Y., Azoulay, L., Nie, R., Dell’Aniello, S., Yu, O. H. Y., & Renoux, C. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.022 · Cited by 48
Ayele, H. T., Brunetti, V. C., Renoux, C., Tagalakis, V., & Filion, K. B. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.029 · Cited by 48
Is Testosterone Replacement Therapy in Older Men Effective and Safe?
Yabluchanskiy, A., & Tsitouras, P. D. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00716-2 · Cited by 47
Involvement of p38 MAPK in Leydig cell aging and age-related decline in testosterone
Luo, D., Qi, X., Xu, X., Yang, L., Yu, C., & Guan, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1088249 · Cited by 48
Almoosa, K. F., Gupta, A., Pedroza, C., & Watts, N. B. (2014) · Endocrine Practice · doi:10.4158/ep14003.or · Cited by 46
Corona, G., Rastrelli, G., Maseroli, E., Fralassi, N., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2014) · Andrology · doi:10.1111/j.2047-2927.2014.00241.x · Cited by 46
Transgender populations and HIV: unique risks, challenges and opportunities
Wansom, T., Guadamuz, T. E., & Vasan, S. (2016) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30475-1 · Cited by 46
The safety of available treatments of male hypogonadism in organic and functional hypogonadism
Corona, G., Rastrelli, G., Reisman, Y., Sforza, A., & Maggi, M. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1424831 · Cited by 47
An update on male hypogonadism therapy
Surampudi, P. N., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 46
Metadata
- Authors
- Vigen, R.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Vigen, Rebecca
- ORCID
- Vigen, Rebecca
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2013-11-06
- Volume
- 310
- Issue
- 17
- Pages
- 1829
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2132123717
- Cited by
- 1,003
- References
- 39
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 48 · 2023: 62 · 2022: 52 · 2021: 52 · 2020: 60 · 2019: 70 · 2018: 87 · 2017: 101 · 2016: 96 · 2015: 136 · 2014: 162 · 2013: 5
- FWCI
- 104.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- testosterone replacement therapy, androgen deficiency, hypogonadism, all-cause mortality, myocardial infarction, ischemic stroke, cardiovascular outcomes, coronary artery disease, male veterans, coronary angiography, men's health, hormone replacement therapy, early trial termination, sex differences in cardiovascular risk
- MeSH terms
- Aged, Coronary Artery Disease, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Retrospective Studies, Risk, Testosterone, Veterans, Cohort Studies, Coronary Angiography, Stroke, Andropause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
